These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27691399)

  • 21. Impact of EGFR point mutations on the sensitivity to gefitinib: insights from comparative structural analyses and molecular dynamics simulations.
    Liu B; Bernard B; Wu JH
    Proteins; 2006 Nov; 65(2):331-46. PubMed ID: 16927343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational modeling of an epidermal growth factor receptor single-mutation resistance to cetuximab in colorectal cancer treatment.
    Buch I; Ferruz N; De Fabritiis G
    J Chem Inf Model; 2013 Dec; 53(12):3123-6. PubMed ID: 24219403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Insight for Roles of DR5 Death Domain Mutations on Oligomerization of DR5 Death Domain-FADD Complex in the Death-Inducing Signaling Complex Formation: A Computational Study.
    Yang H; Song Y
    J Mol Model; 2016 Apr; 22(4):89. PubMed ID: 26995783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural insights into a high affinity nanobody:antigen complex by homology modelling.
    Skottrup PD
    J Mol Graph Model; 2017 Sep; 76():305-312. PubMed ID: 28779687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mAb806 binding to epidermal growth factor receptor: a computational study.
    Ng YZ; Kannan S; Lane DP; Fuentes G; Verma CS
    Proteins; 2015 Jan; 83(1):153-68. PubMed ID: 25370927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization.
    Koromyslova AD; Hansman GS
    PLoS Pathog; 2017 Nov; 13(11):e1006636. PubMed ID: 29095961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the interactions between β2 adrenergic receptor and Gs protein by molecular dynamics simulations.
    Feng Z; Hou T; Li Y
    J Chem Inf Model; 2012 Apr; 52(4):1005-14. PubMed ID: 22404225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS; Roy KK; Saxena AK
    J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A water-based mechanism of specificity and resistance for lapatinib with ErbB family kinases.
    Huang Y; Rizzo RC
    Biochemistry; 2012 Mar; 51(12):2390-406. PubMed ID: 22352796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of subcellular localization on the efficiency of EGFR-targeted VHH photosensitizer conjugates.
    van Lith SAM; van den Brand D; Wallbrecher R; Wübbeke L; van Duijnhoven SMJ; Mäkinen PI; Hoogstad-van Evert JS; Massuger L; Ylä-Herttuala S; Brock R; Leenders WPJ
    Eur J Pharm Biopharm; 2018 Mar; 124():63-72. PubMed ID: 29274374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational MD simulations for improvement the affinity of nanobody against PlGF (placenta growth factor): mutagenesis based on electrostatic interactions.
    Forouzesh M; Askerovich Mamedov A; Pourabadeh A; Hosseini M; Hosseinzadeh G; Arezumand R
    J Biomol Struct Dyn; 2020 Aug; 38(12):3750-3756. PubMed ID: 31524085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of a mono-biotinylated EGFR nanobody in the E. coli periplasm using the pET22b vector.
    Noor A; Walser G; Wesseling M; Giron P; Laffra AM; Haddouchi F; De Grève J; Kronenberger P
    BMC Res Notes; 2018 Oct; 11(1):751. PubMed ID: 30348204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB; Aguan K; Mitra S; Bhattacharjee A
    J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of electrostatic interactions in binding of peptides and intrinsically disordered proteins to their folded targets. 1. NMR and MD characterization of the complex between the c-Crk N-SH3 domain and the peptide Sos.
    Xue Y; Yuwen T; Zhu F; Skrynnikov NR
    Biochemistry; 2014 Oct; 53(41):6473-95. PubMed ID: 25207671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanobody-Engineered Natural Killer Cell Conjugates for Solid Tumor Adoptive Immunotherapy.
    Gong L; Li Y; Cui K; Chen Y; Hong H; Li J; Li D; Yin Y; Wu Z; Huang Z
    Small; 2021 Nov; 17(45):e2103463. PubMed ID: 34761524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein-protein interactions between SWCNT/chitosan/EGF and EGF receptor: a model of drug delivery system.
    Rungnim C; Rungrotmongkol T; Kungwan N; Hannongbua S
    J Biomol Struct Dyn; 2016 Sep; 34(9):1919-29. PubMed ID: 26381241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the binding mechanisms of MIF to CXCR2 using theoretical approaches.
    Xu L; Li Y; Li D; Xu P; Tian S; Sun H; Liu H; Hou T
    Phys Chem Chem Phys; 2015 Feb; 17(5):3370-82. PubMed ID: 25526079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based network analysis of activation mechanisms in the ErbB family of receptor tyrosine kinases: the regulatory spine residues are global mediators of structural stability and allosteric interactions.
    James KA; Verkhivker GM
    PLoS One; 2014; 9(11):e113488. PubMed ID: 25427151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico design: extended molecular dynamic simulations of a new series of dually acting inhibitors against EGFR and HER2.
    Ahmed M; Sadek MM; Abouzid KA; Wang F
    J Mol Graph Model; 2013 Jul; 44():220-31. PubMed ID: 23911931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of suramin binding sites on the human group IIA secreted phospholipase A2 by site-directed mutagenesis and molecular dynamics simulation.
    Aragão EA; Vieira DS; Chioato L; Ferreira TL; Lourenzoni MR; Silva SR; Ward RJ
    Arch Biochem Biophys; 2012 Mar; 519(1):17-22. PubMed ID: 22248627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.